Kelly Handley
Cancer Research UK Clinical Trials Unit(GB)University of Birmingham(GB)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Colorectal Cancer Surgical Treatments, Genetic factors in colorectal cancer, Colorectal and Anal Carcinomas, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Value of Mismatch Repair, KRAS , and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer(2011)675 cited
- → aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.(2013)446 cited
- → Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial(2023)408 cited
- → Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer(2011)373 cited
- → HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials(2015)234 cited
- → Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study